Our research team made patient-specific embryonic stem cells and we have the technology to produce them.
I would like to have time to confirm the validity of the technology.
There is no doubt that we produced 11 patient-specific stem cells and possess the core technology to create them again.
Technology for patient-specific embryonic stem cells belongs to South Korea. And you will find out that this is true.
I definitely have the source technology to produce tailored embryonic stem cells. I can replicate the process anytime.